Growth Metrics

Inogen (INGN) Asset Writedowns and Impairment (2016 - 2022)

Inogen (INGN) has disclosed Asset Writedowns and Impairment for 10 consecutive years, with $363000.0 as the latest value for Q4 2022.

  • On a quarterly basis, Asset Writedowns and Impairment fell 40.49% to $363000.0 in Q4 2022 year-over-year; TTM through Dec 2022 was $2.4 million, a 17.51% increase, with the full-year FY2025 number at $822000.0, up 252.79% from a year prior.
  • Asset Writedowns and Impairment was $363000.0 for Q4 2022 at Inogen, down from $508000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $934000.0 in Q1 2022 to a low of -$46000.0 in Q2 2019.
  • A 5-year average of $354550.0 and a median of $366500.0 in 2021 define the central range for Asset Writedowns and Impairment.
  • Biggest YoY gain for Asset Writedowns and Impairment was 1084.38% in 2019; the steepest drop was 129.87% in 2019.
  • Inogen's Asset Writedowns and Impairment stood at $32000.0 in 2018, then skyrocketed by 1084.38% to $379000.0 in 2019, then soared by 48.55% to $563000.0 in 2020, then rose by 8.35% to $610000.0 in 2021, then crashed by 40.49% to $363000.0 in 2022.
  • Per Business Quant, the three most recent readings for INGN's Asset Writedowns and Impairment are $363000.0 (Q4 2022), $508000.0 (Q3 2022), and $618000.0 (Q2 2022).